Cargando…
Validation of an Automated Quantitative Digital Pathology Approach for Scoring TMEM: A Prognostic Biomarker for Metastasis
Metastasis causes ~90% of breast cancer mortality. However, standard prognostic tests based mostly on proliferation genes do not measure metastatic potential. Tumor MicroEnvironment of Metastasis (TMEM), an immunohistochemical biomarker for doorways on blood vessels that support tumor cell dissemina...
Autores principales: | Entenberg, David, Oktay, Maja H., D’Alfonso, Timothy, Ginter, Paula S., Robinson, Brian D., Xue, Xiaonan, Rohan, Thomas E., Sparano, Joseph A., Jones, Joan G., Condeelis, John S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226227/ https://www.ncbi.nlm.nih.gov/pubmed/32244564 http://dx.doi.org/10.3390/cancers12040846 |
Ejemplares similares
-
Tumor Microenvironment of Metastasis (TMEM) Doorways Are Restricted to the Blood Vessel Endothelium in Both Primary Breast Cancers and Their Lymph Node Metastases
por: Ginter, Paula S., et al.
Publicado: (2019) -
Combining TMEM Doorway Score and Mena(Calc) Score Improves the Prediction of Distant Recurrence Risk in HR+/HER2− Breast Cancer Patients
por: Ye, Xianjun, et al.
Publicado: (2022) -
A metastasis biomarker (MetaSite Breast™ Score) is associated with distant recurrence in hormone receptor-positive, HER2-negative early-stage breast cancer
por: Sparano, Joseph A., et al.
Publicado: (2017) -
Racial disparity in tumor microenvironment and distant recurrence in residual breast cancer after neoadjuvant chemotherapy
por: Kim, Gina, et al.
Publicado: (2023) -
Breast Cancer Cell Re-Dissemination from Lung Metastases—A Mechanism for Enhancing Metastatic Burden
por: Borriello, Lucia, et al.
Publicado: (2021)